Please try another search
Lantheus (NASDAQ:LNTH) Holdings, Inc. (NASDAQ:LNTH) Chief Accounting Officer Andrea Sabens has sold a portion of her company stock, according to a recent regulatory filing. On May 13, Sabens sold 341...
Jeffrey S. Humphrey, MD appointed Chief Medical Officer;Jean-Claude Provost, MD named Chief Science Officer BEDFORD, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Lantheus (NASDAQ:LNTH) Holdings, Inc....
Lantheus (NASDAQ:LNTH) Holdings, Inc. (ticker: LNTH), a leader in diagnostic and therapeutic radiopharmaceuticals, has reported a strong start to 2024 in its first-quarter earnings call. The company...
Investing.com - Lantheus Holdings Inc (NASDAQ: LNTH) reported first quarter EPS of $1.69, $0.14 better than the analyst estimate of $1.55. Revenue for the quarter came in at $370M versus the...
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus (NASDAQ:LNTH) Holdings, Inc. (the Company) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET...
SEATTLE - Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a company specializing in radiopharmaceutical cancer treatments, announced today the acquisition of a manufacturing facility in...
BEDFORD, Mass. - Lantheus (NASDAQ:LNTH) Holdings, Inc. (NASDAQ: LNTH), a company specializing in radiopharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has approved the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review